BioSpace News Archive

The NIH’s National Institute of Allergy and Infectious Diseases (NIAID) has awarded a grant to ImmunogenX to conduct a Phase 2 trial for latiglutenase, an investigational drug for celiac disease (CD).

As part of his role at VeraSci, he will assist in the implementation of the trials of both relapsing and progressive forms of multiple sclerosis (MS).

NIH Grant Fuels Development of Once-Weekly Oral Buprenorphine

United American Healthcare Corporation announced that American Sustainable Rubber Company, LLC and The Ohio State University signed a royalty agreement for exclusive rights within the United States to the genetically modified TK Rubber Dandelion, developed at The Ohio State University, to be grown in an indoor hydroponic system for natural rubber production.

Soliton, Inc.,, a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center, announced it has completed the first evaluation timepoint for its proof of concept clinical trial for the treatment of cellulite.

Lifestyle Delivery Systems Inc.,, is pleased to provide its shareholders with an update on the latest stores carrying the Company’s flagship product, CannaStripsTM.

Presentation at the ASPET Annual Meeting at EB 2019 highlights association between a scientifically-weighted multi-gene algorithm and blood pressure response to pharmacotherapy

Preclinical Studies Demonstrating Anti-fibrotic Effect of Integrin Inhibitor to be Presented at American Thoracic Society International Conference

Nearly $525,000 in Funds and Health Care Products Donated to Support 12 Pediatric Health Programs

The company is expanding its software-as-a-medical-device platform to support the optimization of ALL diabetes medications.